IgA Nephropathy Kidney Research Study
Enrollment Status
- Enrolling
Enrolling Patients
About This Study
This kidney research study evaluates the safety and efficacy of an investigational medicine to improve immune regulation. It is part of ongoing kidney disease research aimed at finding better Berger’s disease treatment options. Every study follows a carefully designed protocol with participant safety, quality, and regulatory compliance at the forefront.
Who May Qualify
You may be eligible to participate if you:
- Are between the ages of 18 to 65
- Have been diagnosed with IgA nephropathy
- Are currently receiving care in an intensive care or hospital setting
Additional eligibility criteria apply.
What Participation Involves
Participation includes:
- Study related treatments or standard of care
- Regular assessments and monitoring
- Collection of study-related data and samples
All study-related care is provided at no cost to participants.
Why Participate?
By participating in this study, you may help advance medical research and contribute to the development of new treatments for IgA nephropathy and future patients.
- NOVA Clinical Research is committed to protecting your privacy and ensuring all clinical research studies are conducted in accordance with ethical guidelines and federal regulations.
Interested in This Study?
Fill out the form below and a member of our research team will contact you.
Speak With Our Team
Have questions about this study or want to learn more?